| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-01 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-02 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-03 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-04 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-05 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-06 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-07 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-08 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-09 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-10 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-1-11 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-01 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-02 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-03 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-04 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-05 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-06 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-07 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-08 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-09 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-10 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-11 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-2-12 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-01 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-02 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-03 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-04 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-05 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-06 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-07 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-08 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-09 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-10 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-11 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS000QCMP-3-12 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-1-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-1-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-1-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-1-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-2-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-2-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-2-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-2-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-3-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-3-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-3-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | R00CHRPL1-3-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-1-01 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-1-02 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-1-03 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-1-04 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-2-01 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-2-02 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-2-03 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-2-04 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-3-01 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-3-02 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-3-03 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000MP-3-04 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-1-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-1-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-1-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-1-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-2-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-2-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-2-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-2-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-3-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-3-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-3-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | CS00000RC-3-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041739 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041740 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041742 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041743 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041744 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041746 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041748 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041749 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041752 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041753 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041754 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041756 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041757 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041759 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041760 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041761 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041770 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041771 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041773 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041775 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041776 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041777 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041778 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041780 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041784 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041786 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041787 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041788 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041789 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041792 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041793 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041795 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041797 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041800 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041801 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041802 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041804 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041805 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041806 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041808 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041810 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041813 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041815 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041816 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041817 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041820 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041830 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041831 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041833 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041838 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041840 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041841 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041842 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041843 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041845 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041846 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041847 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041850 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041852 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041854 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041859 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041861 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041869 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041870 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041872 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041873 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041875 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041876 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041879 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041880 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041884 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041886 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041888 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041890 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041891 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041892 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041893 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041894 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041895 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041902 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041903 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041906 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041909 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041913 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041915 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041918 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041919 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041738 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041741 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041745 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041747 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041750 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041751 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041755 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041758 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041762 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041763 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041764 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041765 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041766 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041767 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041768 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041769 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041772 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041774 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041779 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041781 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041782 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041783 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041785 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041790 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041791 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041794 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041796 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041798 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041799 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041803 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041807 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041809 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041811 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041812 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041814 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041818 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041819 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041821 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041822 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041823 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041824 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041825 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041826 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041827 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041828 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041829 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041832 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041834 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041835 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041836 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041837 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041839 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041844 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041848 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041849 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041851 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041853 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041855 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041856 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041857 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041858 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041860 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041862 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041863 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041864 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041865 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041866 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041867 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041868 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041871 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041874 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041877 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041878 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041881 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041882 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041883 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041885 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041887 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041889 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041896 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041897 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041898 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041899 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041900 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041901 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041904 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041905 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041907 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041908 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041910 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041911 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041912 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041914 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041916 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041917 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041920 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041921 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase POSITIVE (Named metabolites) | S00041922 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-01 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-02 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-03 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-04 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-05 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-06 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-07 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-08 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-09 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-10 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-1-11 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-01 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-02 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-03 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-04 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-05 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-06 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-07 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-08 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-09 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-10 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-11 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-2-12 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-01 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-02 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-03 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-04 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-05 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-06 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-07 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-08 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-09 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-10 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-11 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS000QCMP-3-12 | Sample type:batch pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-1-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-1-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-1-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-1-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-2-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-2-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-2-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-2-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-3-01 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-3-02 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-3-03 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | R00CHRPL1-3-04 | Sample type:chear plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-1-01 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-1-02 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-1-03 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-1-04 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-2-01 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-2-02 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-2-03 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-2-04 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-3-01 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-3-02 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-3-03 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000MP-3-04 | Sample type:master pool | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-1-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-1-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-1-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-1-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-2-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-2-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-2-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-2-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-3-01 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-3-02 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-3-03 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | CS00000RC-3-04 | Sample type:red cross plasma | Gender:- | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041739 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041740 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041742 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041743 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041744 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041746 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041748 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041749 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041752 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041753 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041754 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041756 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041757 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041759 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041760 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041761 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041770 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041771 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041773 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041775 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041776 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041777 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041778 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041780 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041784 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041786 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041787 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041788 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041789 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041792 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041793 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041795 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041797 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041800 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041801 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041802 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041804 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041805 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041806 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041808 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041810 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041813 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041815 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041816 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041817 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041820 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041830 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041831 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041833 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041838 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041840 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041841 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041842 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041843 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041845 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041846 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041847 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041850 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041852 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041854 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041859 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041861 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041869 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041870 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041872 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041873 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041875 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041876 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041879 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041880 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041884 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041886 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041888 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041890 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041891 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041892 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041893 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041894 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041895 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041902 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041903 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041906 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041909 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041913 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041915 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041918 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041919 | Sample type:Sample | Gender:female | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041738 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041741 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041745 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041747 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041750 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041751 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041755 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041758 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041762 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041763 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041764 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041765 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041766 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041767 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041768 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041769 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041772 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041774 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041779 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041781 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041782 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041783 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041785 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041790 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041791 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041794 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041796 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041798 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041799 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041803 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041807 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041809 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041811 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041812 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041814 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041818 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041819 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041821 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041822 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041823 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041824 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041825 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041826 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041827 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041828 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041829 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041832 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041834 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041835 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041836 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041837 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041839 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041844 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041848 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041849 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041851 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041853 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041855 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041856 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041857 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041858 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041860 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041862 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041863 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041864 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041865 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041866 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041867 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041868 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041871 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041874 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041877 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041878 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041881 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041882 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041883 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041885 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041887 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041889 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041896 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041897 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041898 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041899 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041900 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041901 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041904 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041905 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041907 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041908 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041910 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041911 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041912 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041914 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041916 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041917 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041920 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041921 | Sample type:Sample | Gender:male | Peak area normalized |
| Reversed Phase NEGATIVE (Named metabolites) | S00041922 | Sample type:Sample | Gender:male | Peak area normalized |
Return to study ST001325 main page
Download data matrix(Obesity and Poor Diet as Susceptibility Factors for Secondhand Smoke in Childhood Asthma Reversed Phase POSITIVE (Named metabolites))
Download data matrix(Obesity and Poor Diet as Susceptibility Factors for Secondhand Smoke in Childhood Asthma Reversed Phase NEGATIVE (Named metabolites))
- Metabolomics Workbench
|